Plasma levels of endothelin-1 increase in patients with sarcoidosis and fall after disease remission.
Plasma levels of endothelin-1 increase in patients with sarcoidosis and fall after disease remission.
复制标题
结节病患者血浆内皮素-1 水平升高,疾病缓解后下降。
DOI:
--
复制
发表时间:
2001
期刊:
影响因子:
--
通讯作者:
E. D'erasmo
中科院分区:
文献类型:
--
作者:
Claudio Letizia;A. Danese;M. G. Reale;C. Caliumi;E. Delfini;S. Subioli;S. Cerci;E. D'erasmo
BACKGROUND
Sarcoidosis is a chronic systemic disease, characterized by an imbalance of immunity processes and the presence of granuloma. Endothelin-1, a new vasoactive and bronchoconstrictive peptide, is a powerful mitogen for smooth muscle cells and fibroblasts and plays a role in the inflammation state. We postulate that endothelin-1 has a role in sarcoidosis.
METHODS
We studied the behaviour of circulating levels of endothelin-1 in 20 patients with sarcoidosis and its correlation with some biochemical parameters of activity disease, such as erythrocyte sedimentation rate (ESR) and serum angiotensin-converting enzyme (SACE). We measured serum levels of ESR, SACE, calcium and plasma endothelin-1 levels in all patients at the beginning of the study and one again in 9 patients with clinical-biochemical remission of disease after steroid treatment.
RESULTS
In patients with sarcoidosis, circulating levels of endothelin-1, SACE and ESR were significantly higher (p<0.001) than those of healthy subjects. Moreover, in patients with pulmonary involvement, there was a significant statistical difference (p<0.001) between endothelin-1 levels and radiological stage compared to normal subjects. In the 9 patients with remission of disease, both endothelin-1 levels and parameters of activity disease normalized.
CONCLUSIONS
Our results seem to suggest that the increase of plasma endothelin-1 levels in active sarcoidosis can represent an expression of the endothelial dysfunction and reflect the picture of cellular activation.